Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASACABG Part B: Multiple Daily Doses of Aspirin Post-CABG
NCT01902498Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in coronary artery disease (CAD), sponsored by Hamilton Health Sciences. Started Jul 2013; status: completed.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01902498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902498.